RBR-29495g招募中未知
Application of a mobilization protocol, based on the functional level, after cardiovascular surgery: a randomized controlled trial
Hospital Universitário da Universidade Federal do Maranhão0 个研究点开始时间: 2020年2月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 60Y（—）
入选标准
- •Adults patients admitted to the ICU after cardiac surgery (myocardial revascularization, valve replacement / repair, correction of thoracic aortic diseases and combined procedures) or vascular surgery (revascularization of upper / lower limbs and correction of abdominal aortic diseases), from January 2020 to June 2021, with modified Barthel index for walking ? 4 will be included
排除标准
- •Cardiorespiratory arrest
- •Brain injury, with motor response <5 (Glasgow coma scale)
- •Recent acute myocardial infarction
- •Unstable fractures
- •Medical guidelines for maintaining absolute rest due to patient severity
- •Unable to understand verbal commands
- •Mechanical ventilation time for more than 24 hours
- •Enrollment in another clinical study
研究者
相似试验
已完成
Unknown
A cost-effective method utilizing both povidone-iodine irrigations and sodium hypochlorite rinsing solution as supplementary measures in treating severe gum disease, aimed at reducing bacterial infections in patientsPeriodontitis stages III-IVOral HealthISRCTN10470122Victor Babe? University of Medicine and Pharmacy Timi?oara45
招募中
不适用
The Effect of ultrasonography in disposition of patientsIRCT20111114008104N14Iran University of Medical Sciences32
招募中
Unknown
Effectiveness of gamification method for delivery protocol training on midwifery studentsatural delivery.Problems related to education and literacyIRCT20180218038783N7Babol University of Medical Sciences35
进行中（未招募）
不适用
Study to continue giving Tivozanib to subjects participating in other studies with TivozanibRenal Cell CarcinomaMedDRA version: 16.1Level: PTClassification code 10067946Term: Renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-013407-66-PLAVEO Pharmaceuticals, Inc.82
进行中（未招募）
不适用
A Protocol to Allow Continued Access to Tivozanib for Subjects Enrolled in Other Tivozanib Protocolsmetastatic renal cell carcinomaMedDRA version: 15.0Level: LLTClassification code 10038400Term: Renal carcinoma stage IVSystem Organ Class: 100000004864MedDRA version: 15.0Level: LLTClassification code 10038399Term: Renal carcinoma stage IIISystem Organ Class: 100000004864MedDRA version: 15.0Level: LLTClassification code 10050076Term: Metastatic renal carcinomaSystem Organ Class: 100000004864EUCTR2009-013407-66-ITAVEO PHARMACEUTICALS, INC.160